4-(4-nitrophenoxy)phenyl prop-2-en-yl ether | 205381-25-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-nitrophenoxy)phenyl prop-2-en-yl ether
• 英文别名: 1-Nitro-4-(4-prop-2-enoxyphenoxy)benzene
• CAS: 205381-25-5
• 化学式: C₁₅H₁₃NO₄
• 分子量: 271.273
• InChiKey: NNSMMMFECCEHJD-UHFFFAOYSA-N

物化性质

• 沸点：
  393.6±27.0 °C(Predicted)
• 密度：
  1.211±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  64.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(4-nitrophenoxy)phenyl prop-2-en-yl ether 在 palladium on activated charcoal 氢气 作用下， 以 邻二氯苯 为溶剂， 生成 4-(4-aminophenoxy)-2-propylphenol
  参考文献：
  名称：

  5-芳基噻唑烷-2,4-二酮类作为选择性PPARγ激动剂。

  摘要：

  设计，合成了一系列含有4-苯氧基苯基侧链的5-芳基噻唑烷-2,4-二酮，并评估了其PPAR激动剂的活性。一种这样的化合物28在db / db小鼠2型糖尿病动物模型中显示出与罗格列酮相当的葡萄糖校正水平。

  DOI：

  10.1016/s0960-894x(03)00257-9
• 作为产物：
  描述：

  4-(4-硝基苯氧基)苯甲醚 在 氢氧化钾 、 三氯化铝 、 mercaptoethyl alcohol 作用下， 以 乙硫醇 为溶剂， 反应 8.08h， 生成 4-(4-nitrophenoxy)phenyl prop-2-en-yl ether
  参考文献：
  名称：

  Structure−Activity Relationship of New Growth Inhibitors of Trypanosoma cruzi

  摘要：

  Several drugs bearing the 4-phenoxyphenoxy skeleton and other closely related structures were designed, synthesized, and evaluated as antiproliferative agents against Trypanosoma cruzi, the etiologic agent of Chagas' disease. The new class of drugs was envisioned by modifying the nonpolar 4-phenoxyphenoxy moiety replacing selected aromatic protons by different groups via electrophilic aromatic substitution reactions as well as introducing a sulfur atom at the polar extreme. Of the designed compounds, sulfur-containing derivatives were shown to be potent antireplicative agents against T. cruzi. Among these drugs, 4-phenoxyphenoxyethyl thiocyanate (compound 56) proved to be an extremely active growth inhibitor of the epimastigote forms of T. cruzi and displayed an IC50 of 2.2 mu M. Under the same assay conditions, this drug was much more active than Nifurtimox, one of the drugs currently in clinical use to control this disease. This thiocyanate derivative was also a very active inhibitor against the intracellular form of the parasite at the nanomolar level. Other sulfur derivatives prepared also exhibited very potent antiproliferative action against T. cruzi. The presence of a sulfur atom at the polar extreme for this family of compounds seems to be very important for biological action because this atom was always associated with high inhibition values. 4-Phenoxyphenoxyethyl thiocyanate presents very good prospective not only as a lead drug but also as a potential chemotherapeutic agent.

  DOI：

  10.1021/jm970860z

文献信息

• ARYLTHIAZOLIDINEDIONE DERIVATIVES
  申请人：Merck & Co., Inc.

  公开号：EP1040102B1

  公开（公告）日：2007-01-24
• 5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists
  作者：Hiroo Koyama、Julia K Boueres、Wei Han、Edward J Metzger、Jeffrey P Bergman、Dominick F Gratale、Daniel J Miller、Richard L Tolman、Karen L MacNaul、Joel P Berger、Thomas W Doebber、Kwan Leung、David E Moller、James V Heck、Soumya P Sahoo

  DOI：10.1016/s0960-894x(03)00257-9

  日期：2003.5

  A series of 5-aryl thiazolidine-2,4-diones containing 4-phenoxyphenyl side chains was designed, synthesized, and evaluated for PPAR agonist activities. One such compound 28 exhibited comparable levels of glucose correction to rosiglitazone in the db/db mouse type 2 diabetes animal model.

  设计，合成了一系列含有4-苯氧基苯基侧链的5-芳基噻唑烷-2,4-二酮，并评估了其PPAR激动剂的活性。一种这样的化合物28在db / db小鼠2型糖尿病动物模型中显示出与罗格列酮相当的葡萄糖校正水平。
• Structure−Activity Relationship of New Growth Inhibitors of <i>Trypanosoma</i> <i>cruzi</i>
  作者：Güendalina M. Cinque、Sergio H. Szajnman、Li Zhong、Roberto Docampo、Andrea J. Schvartzapel、Juan B. Rodriguez、Eduardo G. Gros

  DOI：10.1021/jm970860z

  日期：1998.4.1

  Several drugs bearing the 4-phenoxyphenoxy skeleton and other closely related structures were designed, synthesized, and evaluated as antiproliferative agents against Trypanosoma cruzi, the etiologic agent of Chagas' disease. The new class of drugs was envisioned by modifying the nonpolar 4-phenoxyphenoxy moiety replacing selected aromatic protons by different groups via electrophilic aromatic substitution reactions as well as introducing a sulfur atom at the polar extreme. Of the designed compounds, sulfur-containing derivatives were shown to be potent antireplicative agents against T. cruzi. Among these drugs, 4-phenoxyphenoxyethyl thiocyanate (compound 56) proved to be an extremely active growth inhibitor of the epimastigote forms of T. cruzi and displayed an IC50 of 2.2 mu M. Under the same assay conditions, this drug was much more active than Nifurtimox, one of the drugs currently in clinical use to control this disease. This thiocyanate derivative was also a very active inhibitor against the intracellular form of the parasite at the nanomolar level. Other sulfur derivatives prepared also exhibited very potent antiproliferative action against T. cruzi. The presence of a sulfur atom at the polar extreme for this family of compounds seems to be very important for biological action because this atom was always associated with high inhibition values. 4-Phenoxyphenoxyethyl thiocyanate presents very good prospective not only as a lead drug but also as a potential chemotherapeutic agent.